
News
The Gr8 Eye Movement campaign by Prevent Blindness and Regeneron emphasizes the critical role of caregivers in eye health, revealing significant gaps in caregivers' awareness of retinal diseases and aging-related vision loss.

News
The Gr8 Eye Movement campaign by Prevent Blindness and Regeneron emphasizes the critical role of caregivers in eye health, revealing significant gaps in caregivers' awareness of retinal diseases and aging-related vision loss.

OCT-based AI analysis brings changes in GA and therapeutic responses into sharp focus.

These residents won second place at the Eyecelerator competition held prior to this month’s American Academy of Ophthalmology conference in Chicago, receiving a $15,000 prize—the first such prize awarded to residents—for their development of a smartphone device designed to take fundus images.

News
The company reported that Duravyu 2.7mg demonstrated an early and sustained anatomical improvement mirroring BCVA results with a 68 micron reduction in CST. Full topline data is anticipated in Q1 of 2025.

News
According to the company, Duravyu 2.7 mg demonstrated an early and sustained anatomical improvement mirroring BCVA results with a 68 micron reduction in CST. Full topline data is anticipated in Q1 of 2025.

News
A study led by researchers at the University of Birmingham finds AI-powered models can match ophthalmologists in diagnosing infectious keratitis, offering promise for global eye care improvements.

News
Tarver is a board-certified ophthalmologist with a doctorate in epidemiology and has held various leadership positions at the FDA as a medical device regulator, helping drive strategic initiatives, conduct clinical research and changing organizational culture.

Vikas Chopra, MD, led a course on minimally invasive glaucoma surgery (MIGS) and its impact on glaucoma care. He explained that MIGS enables ophthalmologists to intervene earlier and more safely, which can lead to better outcomes for patients.

Ophthalmologists discuss advancing treatment strategies to improve outcomes.

Victoria L Tseng, MD, PhD, assistant professor of ophthalmology and a glaucoma specialist at UCLA and scientist at Doheny Eye Institute, spoke with the Eye Care Network at this year's AAO meeting about the "Glaucoma Original Papers" session and discussed the papers presented in the session by Giovanni Montesano, MD; Jason D Horowitz, MD; Christopher M Edwards, BS; Eamonn Thomas Fahy, BMBCH; Kiana Tavakoli, MD; Hani El Helwe, MD; and Joseph F Panarelli, MD.

John Josephson, MD, from the Eye Specialists and Surgeons of Northern Virginia, shared insights on office-based surgeries and how it allows for the addition of new technologies and new procedures at this year's AAO meeting held in Chicago, Illinois.


Brian Francis, MD, from the Doheny Eye Institute and the UCLA Department of Ophthalmology, shared insights on MIGS techniques and the labs and didactic available while at this year's AAO meeting held in Chicago, Illinois.


Jonathan Brugger, MD, shared insights on the correlation of central retinal vein occlusions, or branch retinal vein occlusions, in young adults who consume numerous energy drinks.

This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.

Henderson’s presentation touches on the shift in medical education from traditional learning to AI and robotics.

Weijie Violet Lin, MD, presented findings from her research, which revealed that post-cross-linking complications were low and highlighted key risk factors and the importance of early identification to enhance long-term patient outcomes.

New investment from Sanoptis will support Ikerian technology for large-scale, AI-enabled data management

CBNS, such as turmeric, are natural anti-inflammatory and antioxidant agents that may confer benefits against AMD.

At the American Academy of Ophthalmology (AAO) meeting in Chicago, Illinois, Brent Kramer, MD, he talked with the Eye Care Network about using the MKO Melt in lieu of IV anaesthesia ahead of ocular surgery.


News
John D. Sheppard, MD, MMSc, FACS, spoke with the Eye Care Network to provide some insight on post hoc analysis of the ESSENCE 1 trial dor dry eye disease.

A time line marked by innovation, collaboration, and improving patient outcomes.


Victoria L. Tseng, MD, PhD, discusses SLT, microshunts and what glaucoma specialists can learn from large data sets


News
According to the company, the second Phase 3 LUCIA pivotal trial first patient dosing is expected by end of 2024 with topline data anticipated in 2026.

During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr., MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.

A study clarifies the relationship between postnatal weight gain and ROP development.